Page 93 - Read Online
P. 93

efficient to use than BMSCs. These characteristics,   CONCLUSION
          coupled with the observation that there is no significant
          difference between ASCs and BMSCs in facilitating   Sensory and motor regeneration are major hurdles that
          nerve regeneration, points to ASCs as being a more   must be addressed to realize the fullest potential of VCA.
          efficient option in stem cell‑based enhancement of nerve   Advances continue to be made in peripheral nerve repair, and
          regeneration. [65]                                  these results must be explored in the context of transplant
                                                              surgery. Results in post‑VCA functional outcomes continue to
          While the transplantation of Schwann cells into nerve   improve, and soon, we can expect more consistent, reliable,
          conduits has demonstrated increased regenerative    and faster recovery of sensation and motor control to donor
                  [66]
          potential,  ASCs  have  also been  demonstrated to have   tissues. Exciting advancements in the area of ASC‑enhanced
          a pro‑regenerative effect on growing axons. [67‑70]  The   nerve regeneration may offer a promising frontier towards
          mechanism for this effect is in the differentiation of ASCs   addressing this challenging question.
          into Schwann cell‑like phenotypes in the context of nerve
          injury  and regeneration.  Interestingly,  undifferentiated   REFERENCES
                                                         [71]
          ASCs  (uASCs) can also promote  nerve growth.
          In  vitro  differentiation  of uASCs  into  Schwann cells prior   1.   Chim H, Amer H, Mardini S, Moran SL. Vascularized composite allotransplant
          to  seeding  demonstrated  no  significant  difference  as   in the realm of regenerative plastic surgery. Mayo Clin Proc 2014;89:1009‑20.
          compared to uASCs in the graft‑guided regeneration   2.   Fischer S, Lian CG, Kueckelhaus M, Strom TB, Edelman ER, Clark RA,
          of a ten millimeter  injury of rat sciatic nerve.  Similar   Murphy  GF, Chandraker  AK, Riella  LV, Tullius  SG, Pomahac  B. Acute
                                                  [72]
                                                                  rejection in vascularized composite allotransplantation. Curr Opin Organ
          findings were demonstrated in facial nerve repair with   Transplant 2014;19:531‑44.
          uASC/differentiated ASC seeding of the graft.  A large   3.   Oliveira JT, Bittencourt‑Navarrete RE, de Almeida FM, Tonda‑Turo C,
                                                  [68]
          meta‑analysis published in July 2014 examining data from   Martinez AM, Franca JG. Enhancement of median nerve regeneration by
                                                                  mesenchymal stem cells engraftment in an absorbable conduit: improvement
          forty‑four  animal studies  revealed that  the  use  of ASCs   of peripheral nerve morphology with enlargement of somatosensory cortical
          in nerve grafts offers significant benefits toward nerve   representation. Front Neuroanat 2014;8:111.
          regeneration in sciatic, median, ulnar, and  radial  nerve   4.   Scheib J, Höke A. Advances in peripheral nerve regeneration. Nat Rev Neurol
          lesion models in rats, dogs, monkeys, and mice. [73]  5.   2013;9:668‑76.
                                                                  Raff  MC,  Whitmore  AV,  Finn  JT.  Axonal  self‑destruction  and
          The regenerative benefits  of ASCs  require  their  seeding   6.   neurodegeneration. Science 2002;296:868‑71.
                                                                  Glaus  SW,  Johnson  PJ,  Mackinnon  SE.  Clinical  strategies  to  enhance
          along the path of the growing axon sprouts, as well as   nerve regeneration in composite tissue allotransplantation.  Hand Clin
          being in an environment that maintains the population   2011;27:495‑509, ix.
          for the weeks to months required for axonal regrowth.   7.   Oyamatsu  H,  Koga  D,  Igarashi  M,  Shibata  M,  Ushiki  T.  Morphological
          Existing  Food and Drug  Administration‑approved nerve   assessment of early axonal regeneration in end‑to‑side nerve coaptation
                                                                  models. J Plast Surg Hand Surg 2012;46:299‑307.
          conduits with specialized matrices for ASC maintenance   8.   Pomahac  B, Pribaz  J. Facial composite tissue allograft. J  Craniofac Surg
          adequately  meets  these  requirements,  thereby  creating   2012;23:265‑7.
          a  microenvironment  in  which such stem  cells can   9.   Lykissas MG. Current concepts in end‑to‑side neurorrhaphy. World J Orthop
                                                                  2011;2:102‑6.
          readily affect pro‑regenerative signals on growing axons   10.  Audolfsson T, Rodríguez‑Lorenzo A, Wong C, Cheng A, Kildal M, Nowinski D,
          in  a  spatially  constrained path.  ASCs  are  capable of   Rozen S. Nerve transfers for facial transplantation: a cadaveric study for
          secreting  nerve  growth factors, vascular endothelial   motor and sensory restoration. Plast Reconstr Surg 2013;131:1231‑40.
          growth factor, and brain‑derived neurotrophic  factor,   11.  Rinker B, Vyas KS. Clinical applications of autografts, conduits, and allografts
                                                                  in repair of nerve defects in the hand: current guidelines. Clin Plast Surg
          among a wider set of cytokines and other cell signaling   2014;41:533‑50.
          molecules.  The strength of a cellular graft over one that   12.  Rivlin M, Sheikh E, Isaac R, Beredjiklian PK. The role of nerve allografts and
                   [71]
          merely elutes  neurotrophic factors is  that the  molecular   conduits for nerve injuries. Hand Clin 2010;26:435‑46, viii.
          microenvironment  can be  regulated by  ASCs  in  response   13.  Moore AM, Kasukurthi R, Magill CK, Farhadi HF, Borschel GH, Mackinnon SE.
                                                                  Limitations of conduits in peripheral nerve repairs. Hand (N Y) 2009;4:180‑6.
          to the penetrating sprouts. [74]                    14.  Mackinnon  SE, Doolabh  VB, Novak  CB, Trulock  EP. Clinical outcome
                                                                  following nerve allograft transplantation. Plast Reconstr Surg 2001;107:1419‑29.
          ASCs prove to be a promising area of research for the   15.  Midha R, Mackinnon SE, Becker LE. The fate of Schwann cells in peripheral
          facilitation of nerve regeneration in VCA. Early in  vivo   nerve allografts. J Neuropathol Exp Neurol 1994;53:316‑22.
          research demonstrating seeding of these cells into   16.  Elkwood AI, Holland NR, Arbes SM, Rose MI, Kaufman MR, Ashinoff RL,
          artificial conduits and grafts has provided promising   Parikh MA, Patel TR. Nerve allograft transplantation for functional restoration
                                                                  of the upper extremity: case series. J Spinal Cord Med 2011;34:241‑7.
          results. However, these remain restricted to animal   17.  Gold BG. FK506 and the role of immunophilins in nerve regeneration.
          models  of  the  peripheral  nerve  lesion.  The  combined   Mol Neurobiol 1997;15:285‑306.
          promise  of  beneficial  immunomodulatory  effects  and   18.  Toll EC, Seifalian AM, Birchall MA. The role of immunophilin ligands in nerve
                                                                  regeneration. Regen Med 2011;6:635‑52.
          enhanced nerve regeneration makes these cells a     19.  Jensen JN, Brenner MJ, Tung TH, Hunter DA, Mackinnon SE. Effect of
          tantalizing  therapeutic  supplementation  in  VCA.  The   FK506 on peripheral nerve regeneration through long grafts in inbred swine.
          extent of these benefits as  a clinical application in VCA   Ann Plast Surg 2005;54:420‑7.
          remains to be studied.                              20.  Landin L, Cavadas PC, Gonzalez E, Rodriguez JC, Caballero A. Functional
                                                                  outcome after facial allograft transplantation in rats. J Plast Reconstr Aesthet Surg
          A  summary  of  recent  and  pertinent  publications    2008;61:1034‑43.
          regarding ASCs in VCA/nerve regeneration can be found   21.  Song Y, Wang Z, Wang Z, Zhang H, Li X, Chen B. Use of FK506 and bone
                                                                  marrow mesenchymal stem cells for rat hind limb allografts. Neural Regen Res
          in Table 4.                                             2012;7:2681‑8.

          Plast Aesthet Res || Vol 2 || Issue 4 || Jul 15, 2015                                             233
   88   89   90   91   92   93   94   95   96   97   98